Adversarial Validation — Practitioner Tier

The AI-generated clinical brief you just used — when was the last time anyone challenged it?

38% of AI-generated clinical content contains fabricated citations or unsupported claims. The adversarial validation infrastructure used by enterprise biopharma teams is now available to individual practitioners who cannot afford to be the ones who didn't check.

38%
AI hallucination rate in
clinical content generation
Nature Medicine, 2024
$2.1M
Average malpractice
settlement, United States
Diederich Healthcare, 2024
68%
Regulatory changes learned
after enforcement action
FDA Compliance Review, 2023
What You're Actually Carrying

How are you supposed to know which AI-generated clinical output is wrong — before it reaches a patient?

Every clinical decision, protocol recommendation, and formulary choice now rests on intelligence that may have been generated by AI and never adversarially validated. You probably don't know which outputs those are. That's precisely the problem.

Enterprise biopharma teams have built dedicated adversarial validation operations. Individual practitioners have been left with general-purpose AI tools that hallucinate clinical data at a documented rate of 38%, with no source verification and no one accountable when the output is wrong.

The gap between what AI generates and what has actually been verified is the exposure layer most practitioners are operating inside right now. It is unpriced, unmeasured, and the regulators who will eventually ask about it are not waiting for practitioners to catch up.

Exposure Surface
38%
AI Output Fabrication
Clinical content generated by general-purpose AI contains fabricated citations, dosage errors, or unsupported claims.
Nature Medicine, 2024
$340K
Missed Signal Cost
Average cost of a missed competitive or regulatory signal for practices operating in regulated therapeutic areas.
McKinsey Health Insights, 2023
47%
Clinical Error Attribution
Clinical errors where root cause traces to incomplete, outdated, or unverified intelligence inputs.
WHO Patient Safety Report, 2023
0
Practitioner Tools With Source Chain
No existing practitioner-grade tool provides end-to-end source verification with regulatory cross-referencing.
AimwellBio market analysis
14 days
Avg. Regulatory Awareness Lag
Time between a regulatory action and when a typical practitioner becomes aware, across FDA, EMA, and state-level bodies.
Regulatory Affairs Professionals Society
3.2x
Liability Multiplier
Practitioners using AI-generated clinical recommendations without verification face 3.2x higher liability exposure.
American Medical Assoc., 2024
Practitioner Applications
Chiropractor
Peptide & Supplement Protocol Verification
Exposure: Protocol recommendations based on unverified compound data, FDA status changes, and adverse event signals not yet surfaced by standard sources.
System output: Continuous compound verification against FDA databases, clinical trial registries, and FAERS adverse event reports. Source chain attached to every output.
Biotech Scientist
Competitive Filing & Patent Surveillance
Exposure: Competitor patent filings, clinical trial progressions, and licensing activity that intersects active research domains — detected late or not at all.
System output: Continuous monitoring across USPTO, EPO, and ClinicalTrials.gov. Alerts generated when competitor activity crosses defined research boundaries.
Functional Medicine Clinic
Multi-Protocol Interaction Verification
Exposure: Therapy combinations prescribed across modalities with incomplete cross-referencing of interaction data and contraindication signals.
System output: Protocol combination verification against verified clinical databases. Contraindication flags generated for interactions not captured by standard reference tools.
Dental Practice Owner
Supplier & Material Risk Monitoring
Exposure: Materials, devices, and suppliers subject to FDA recalls, compliance actions, or safety alerts that are not systematically tracked at the practice level.
System output: Continuous tracking of FDA recalls, supplier compliance records, and material safety communications. Risk surfaced before it enters clinical use.
Health System Pharmacist
Formulary & Drug Safety Surveillance
Exposure: Formulary decisions influenced by safety signal data that is incomplete, delayed, or not cross-referenced against emerging FDA FAERS data.
System output: Real-time FAERS monitoring, EMA signal tracking, and peer-reviewed safety data aggregation. Emerging signals surfaced 30+ days before typical FDA action timelines.
Peptide Specialist
Compound Sourcing & Regulatory Status
Exposure: Compounds sourced from compounding pharmacies with compliance status that varies by state, changes without notice, and is not systematically monitored.
System output: Continuous compliance verification across compounding sources, ingredient supply chains, and state-by-state regulatory status for all active compounds.
Deployment
01
Select Access Tier
Scope and coverage determined by practice type and operational requirements.
02
Intelligence Intake
Adaptive assessment configures monitoring domains, regulatory jurisdictions, and entity watchlists.
03
Initial Dossier
Baseline intelligence dossier delivered within 48 hours. Covers current landscape, active risks, and monitoring configuration.
04
Continuous Operation
Verified intelligence delivered at cadence. All outputs carry full source chain and verification status.
Access Tiers

Individual Practitioner Access

Each tier includes the Decision Integrity Engine with hallucination containment and verified source chain. No contracts. Cancel at any time.

Signal
$229
per month
Baseline verified intelligence for individual practitioners monitoring a single domain.
  • Weekly intelligence briefing
  • 1 therapeutic area monitored
  • FDA + 1 additional regulatory body
  • Hallucination containment (standard)
  • Verified source chain on all outputs
  • Critical signal alerts via email
Start My Validation Assessment
Shield Recommended
$349
per month
Full decision protection for practitioners managing multiple domains and competitive exposure.
  • Daily intelligence briefing
  • 3 therapeutic areas monitored
  • FDA + EMA + state-level tracking
  • Hallucination containment (advanced)
  • Competitive entity monitoring (10 entities)
  • Drug interaction & protocol verification
  • Supplier compliance monitoring
  • Priority alerts via email + Slack
Deploy My Validation Layer
Command
$649
per month
Complete intelligence infrastructure for multi-practitioner operations and group practices.
  • Real-time intelligence feed
  • Unlimited therapeutic areas
  • Global regulatory coverage (FDA, EMA, MHRA, PMDA)
  • Hallucination containment (enterprise-grade)
  • Unlimited entity monitoring
  • Custom intelligence dossiers (monthly)
  • Patent & IP filing surveillance
  • Multi-user access (5 seats)
  • Dedicated intelligence analyst (async)
  • Quarterly strategy review
Request Command Access
SOC 2-aligned controls HIPAA-conscious data handling Zero Data Resale End-to-End Encryption
Intelligence data is never shared, never sold, and never used to train AI models. All practitioner data remains under sole ownership.
Enterprise & Institutional

For organizations, health systems, and institutional mandates.

Growth, Enterprise, and Sovereign tiers are configured for multi-team intelligence operations with custom integrations, dedicated analysts, and SLA-backed delivery.

Request Enterprise Access
01 DECIDE 02 VERIFY 03 TRACE 04 STANDARD

The practitioners who validated their AI-generated science first will set the standard of care. The rest will explain, under oath, why they didn't.

You are already making decisions on AI-generated intelligence. The only question is whether that intelligence was ever adversarially challenged — whether its sources are traceable, its claims verified, and the system that produced it accountable. The practitioners who answer yes first have already separated themselves from everyone still hoping the question never gets asked.

See which tier fits your practice →
Federated Health Intelligence Network

Verified Contributors

Every listed profile is a credentialed researcher, clinician, or regulatory professional whose datasets feed the Cortex engine. Apply to join →

SHARE THIS
AIMN : AimwellBio
Decision Integrity Engine access for individual biopharma and healthcare practitioners. Verified intelligence infrastructure at the individual level.